Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Connexion
Les utilisateurs de lecteurs d'écran peuvent cliquer sur ce lien pour activer le mode d'accessibilité. Celui-ci propose les mêmes fonctionnalités principales, mais il est optimisé pour votre lecteur d'écran.

Brevets

  1. Recherche avancée dans les brevets
Numéro de publicationUS20030033021 A1
Type de publicationDemande
Numéro de demandeUS 10/195,334
Date de publication13 févr. 2003
Date de dépôt15 juil. 2002
Date de priorité16 juil. 2001
Autre référence de publicationEP1416886A2, EP1416886A4, EP1416887A2, EP1416887A4, US8012205, US20030033022, WO2003007787A2, WO2003007787A3, WO2003007879A2, WO2003007879A3
Numéro de publication10195334, 195334, US 2003/0033021 A1, US 2003/033021 A1, US 20030033021 A1, US 20030033021A1, US 2003033021 A1, US 2003033021A1, US-A1-20030033021, US-A1-2003033021, US2003/0033021A1, US2003/033021A1, US20030033021 A1, US20030033021A1, US2003033021 A1, US2003033021A1
InventeursPamela Plouhar, Herbert Schwartz, Prasanna Malaviya
Cessionnaire d'originePlouhar Pamela Lynn, Schwartz Herbert Eugene, Prasanna Malaviya
Exporter la citationBiBTeX, EndNote, RefMan
Liens externes: USPTO, Cession USPTO, Espacenet
Cartilage repair and regeneration scaffold and method
US 20030033021 A1
Résumé
A method for the repair of a cartilaginous tissue defect, a cartilage repair device and a method of making a cartilage repair device are disclosed. In the method for the repair of a cartilaginous tissue defect, a device comprising a synthetic polymer is implanted into the defect, and a biological lubricant is administered to the defect. The device comprises a synthetic polymer and a biological lubricant.
Images(6)
Previous page
Next page
Revendications(51)
1. A method for the repair of a cartilagenous tissue defect comprising the steps of
implanting a scaffold into the defect, and
administering a biological lubricant to the defect, wherein the biological lubricant is not crosslinked to the scaffold.
2. The method of claim 1, wherein the implanting step and administering step take place during a single surgical procedure.
3. The method of claim 2, further comprising an additional post-operative administration of biological lubricant to the defect.
4. The method of claim 1, wherein the biological lubricant comprises a GAG.
5. The method of claim 1, wherein the biological lubricant is selected from the group consisting of: hyaluronic acid; a salt of hyaluronic acid; sodium hyaluronate; dermatan sulfate; heparan sulfate; chondroiton sulfate; keratan sulfate; synovial fluid; a component of synovial fluid; vitronectin; and rooster comb hyaluronate.
6. The method of claim 1, further comprising the step of
closing an incision site created to implant the scaffold, and
wherein the administering step is subsequent to the closing step, and the biological lubricant is administered to the defect via injection in the area of the defect.
7. The method of claim 1, wherein the defect is in the knee and the biological lubricant is administered by injection into the knee joint cavity.
8. The method of claim 1, wherein the biological lubricant is administered to the defect by saturating the scaffold with a biological lubricant solution prior to implantation.
9. The method of claim 1, wherein the scaffold is provided pre saturated with biological lubricant
10. The method of claim 2, further comprising the step of
providing a series of additional biological lubricant injections to the area of the defect subsequent to the surgical procedure.
11. The method of claim 10, wherein the defect is in the knee joint and the injections are into the knee joint cavity.
12. The method of claim 10, wherein the series of additional biological lubricant injections comprises a first additional biological lubricant injection two weeks subsequent to the surgical procedure and a second additional biological lubricant injection four weeks subsequent to the surgical procedure.
13. The method of claim 1, wherein the defect is in a meniscus and implanting step is a surgical procedure comprising
performing a partial menisectomy to create a space,
placing the scaffold into the space, and
fixing the scaffold to surrounding meniscal tissue.
14. The method of claim 1, wherein the scaffold comprises a synthetic polymer.
15. The method of claim 14, wherein the synthetic polymer has a structure selected from the group consisting of woven, knitted, warped knitted, nonwoven, braided, and foamed.
16. The method of claim 14, wherein the synthetic polymer is selected from the group consisting of PLA, PGA, PCL, PDO, TMC, PVA, copolymers thereof, and blends thereof.
17. The method of claim 14, wherein the scaffold further comprises an extracellular matrix.
18. The method of claim 1, wherein the device further comprises at least one additional substance selected from the group consisting of: a bioactive agent; a biologically derived substance; cells; and a biocompatible inorganic material.
19. A method for the repair of a cartilaginous tissue defect comprising the steps of
implanting a scaffold comprising a synthetic polymer into the defect, and
administering a GAG to the defect, wherein the GAG is not crosslinked to the scaffold.
20. The method of claim 19, wherein the GAG is not crosslinked to the scaffold.
21. The method of claim 20, wherein the implanting step and administering step take place during a single surgical procedure.
22. The method of claim 21, further comprising an additional post-operative administration of a biological lubricant to the defect.
23. The method of claim 22, wherein the biological lubricant of the additional post-operative administration comprises the GAG.
24. The method of claim 23, wherein the GAG comprises HA.
25. The method of claim 20, further comprising the step of
closing an incision site created to implant the scaffold, and
wherein the administering step is subsequent to the closing step, and the GAG is administered to the defect via injection in the area of the defect.
26. The method of claim 25, wherein the defect is in the knee and the injection is into the knee joint cavity.
27. The method of claim 20, wherein the biological lubricant is administered to the defect by saturating the scaffold with a biological lubricant solution prior to implantation.
28. The method of claim 20, wherein the scaffold is provided pre-saturated with biological lubricant.
29. The method of claim 19, further comprising a series of post-operative biological lubricant injections wherein the series of post-operative biological lubricant injections comprises a first post-operative lubricant injection two weeks subsequent to the surgical procedure and a second post-operative biological lubricant injection four weeks subsequent to the surgical procedure.
30. The method of claim 19, wherein the defect is in a meniscus and implanting step comprises
performing a partial menisectomy to create a space,
placing the scaffold into the space, and
fixing the scaffold to surrounding meniscal tissue.
31. The method of claim 19, wherein the GAG is HA.
32. The method of claim 19, wherein the GAG is crosslinked to the scaffold.
33. The method of claim 19, wherein the scaffold consists essentially of the synthetic polymer.
34. A cartilage repair device comprising a synthetic polymer scaffold and a biological lubricant applied to the polymer.
35. The cartilage repair device of claim 34, wherein the biological lubricant comprises a solution.
36. The cartilage repair device of claim 34, wherein the biological lubricant solution comprises a GAG.
37. The cartilage repair device of claim 36, wherein the biological lubricant solution comprises HA.
38. The cartilage repair device of claim 37, wherein the HA is a high molecular weight sodium hyaluronate.
39. The cartilage repair device of claim 34, wherein the device further comprises a biologic component.
40. The cartilage repair device of claim 39, wherein the biologic component comprises an ECM.
41. The cartilage repair device of claim 40, wherein the ECM matrix comprises tissue derived from a source selected from the group consisting of: vertebrate small intestine submucosa; vertebrate liver basement membrane; vertebrate bladder submucosa; vertebrate stomach submucosa; vertebrate alimentary tissue; vertebrate respiratory tissue; and vertebrate genital tissue.
42. The cartilage repair device of claim 34, further comprising an additional material selected from the group consisting of: a bioactive agent; a biologically derived substance; and cells.
43. The cartilage repair device of claim 34 wherein the synthetic polymer scaffold comprises a plug configured to be positioned in an opening formed in damaged cartilage.
44. The cartilage repair device of claim 43 wherein the plug is secured to an anchor.
45. The cartilage repair device of claim 43 further comprising an anchor configured to secure the plug in the opening.
46. A method of making a cartilage repair device comprising:
providing a scaffold;
providing a biological lubricant in liquid form; and
wetting the scaffold with the liquid biological lubricant to form a wet implant.
47. The method of claim 46, further comprising packaging the wet implant and terminally sterilizing the packaged wet implant.
48. The method of claim 46, further comprising drying the wet implant, packaging the dry implant and terminally sterilizing the packaged dry implant.
49. The method of claim 46, wherein the scaffold comprises a synthetic polymer.
50. The method of claim 49, wherein the scaffold further comprises a naturally occurring extracellular matrix.
51. The method of claim 46, further comprising incorporating into the wet implant a material selected from the group consisting of: a bioactive agent; a biologically derived substance; and cells.
Description
  • [0001]
    This application claims priority to U.S. Provisional Application No. 60/388,724, filed Jun. 14, 2002, and U.S. Provisional Application No. 60/305,786, filed Jul. 16, 2001, hereby incorporated by reference.
  • CROSS REFERENCE
  • [0002]
    Cross reference is made to copending U.S. patent applications Ser. No. ______ entitled “Meniscus Regeneration Device and Method” (Attorney Docket No. 265280-71141, DEP-745); Ser. No. ______ entitled “Devices from Naturally Occurring Biologically Derived Materials” (Attorney Docket No. 265280-71142, DEP-748); Ser. No. ______ entitled “Cartilage Repair Apparatus and Method” (Attorney Docket No. 265280-71143, DEP-749); Ser. No. ______ entitled “Unitary Surgical Device and Method” (Attorney Docket No. DEP-750); Ser. No. ______ entitled “Hybrid Biologic/Synthetic Porous Extracellular Matrix Scaffolds” (Attorney Docket No. 265280-71144, DEP-751); Ser. No. ______ entitled “Cartilage Repair and Regeneration Device and Method” (Attorney Docket No. 265280-71145, DEP-752); Ser. No. ______ entitled “Porous Extracellular Matrix Scaffold and Method” (Attorney Docket No. 265280-71146, DEP-747); and Ser. No. ______ entitled “Porous Delivery Scaffold and Method” (Attorney Docket No. 265280-71207, DEP-762), each of which is assigned to the same assignee as the present application, each of which is filed concurrently herewith, and each of which is hereby incorporated by reference. Cross reference is also made to U.S. patent application Ser. No. 10/172,347 entitled “Hybrid Biologic-Synthetic Bioabsorbable Scaffolds” which was filed on Jun. 14, 2002, which is assigned to the same assignee as the present application, and which is hereby incorporated by reference.
  • BACKGROUND OF THE INVENTION
  • [0003]
    Articular cartilage is a type of hyaline cartilage that lines the surfaces of the opposing bones in a diarthrodial joint (e.g. knee, hip, shoulder, etc.). Articular cartilage provides a near-frictionless articulation between the bones, while also functioning to absorb and transmit the compressive and shear forces encountered in the joint. Further, since the tissue associated with articular cartilage is aneural, these load absorbing and transmitting functions occur in a painless fashion in a healthy joint.
  • [0004]
    Fibrocartilage is found in diarthrodial joints, symphyseal joints, intervertebral discs, articular discs, as inclusions in certain tendons that wrap around a pulley, and at insertion sites of ligaments and tendons into bone. Made of a mixture of collagen type I and type II fibers, fibrocartilage can also be damaged, causing pain in the affected joint. It is understood for purposes of this application that the term “cartilage” includes articular cartilage and fibrocartilage.
  • [0005]
    When cartilage tissue is no longer healthy it can cause debilitating pain in the joint. For example, articular cartilage health can be affected by disease, aging, or trauma, all of which primarily involve a breakdown of the matrix consisting of a dense network of proteoglycan aggregates, collagen fibers, and other smaller matrix proteins. Tissue cells are unable to induce an adequate healing response because they are unable to migrate, being enclosed in lacunae surrounded by a dense matrix. Further, since the tissue is avascular, initiation of healing by circulating cells is limited. Similarly, damage or degeneration of knee fibrocartilage i.e. the menisci, is a common occurrence. A damaged or degenerated meniscus has little ability to heal or repair itself because the pathology frequently occurs in the avascular part of the tissue.
  • [0006]
    Several articular cartilage repair strategies have been attempted in the past. These include surgical techniques such as microfracturing or performing abrasion arthroplasty on the bone bed to gain vascular access, and hence, stimulate extrinsic repair in the defective region. The long-term outcome of these techniques, however, has been known to result in mechanically inferior fibrocartilagenous tissue.
  • [0007]
    Another surgical technique is mosaicplasty or osteochondral autograft transfer system (OATS). In this case, cylindrical plugs of healthy articular cartilage from a low-load bearing region of the knee are taken and transplanted into the defective region. This technique, however, can result in excessive donor-site morbidity and associated pain. Additionally, surgeons have reported that the gaps between the round transplants are frequently filled with fibrocartilage which can eventually erode away, thus potentially compromising the integrity of repair throughout the affected area.
  • [0008]
    The only FDA-approved cartilage treatment product in the market involves autologous chondrocyte implantation (CartiCel™). Autologous chondrocyte implantation involves performing an initial biopsy of healthy cartilage from the patient, isolating the cells from the tissue, expanding the cells in vitro by passaging them in culture, and then reintroducing the cells into the defective area. The cells are retained within the defect by applying a periosteal tissue patch over the defect, suturing the edges of the patch to the host tissue, and then sealing with fibrin glue. The efficacy of this expensive procedure, however, has recently been put into question by studies that have shown that only a few of the injected cells are retained within the defect and that they may not significantly contribute to the repair process. The healing observed is similar to that observed with microfracture or abrasion of the bone bed, suggesting that it is the preparation of the bone bed and not the introduction of the cells that facilitates the healing process.
  • [0009]
    Tissue engineering strategies for healing cartilage are being investigated by several academic and commercial teams and show some promise. One approach primarily involves using a biocompatible biologic or synthetic scaffold to deliver cells or stimulants to the defect site. The scaffold material can be a purified biologic polymer in the form of a porous scaffold or a gel (purified collagens, glycoproteins, proteoglycans, polysaccharides, or the like in various combinations) or porous scaffolds of synthetic biodegradable polymers (PLA, PGA, PDS, PCL, or the like, in various combinations). Several challenges remain with this approach, however. Some of these challenges include retention of the active stimulant at the defect site, inability to control the rate of release of the stimulant (resulting in tissue necrosis due to overdose), and cytotoxicity of the cells due to the degradation by-products of the synthetic polymers.
  • [0010]
    In another technique, various collagen scaffolds have been used to provide a scaffold for repair and regeneration of damaged cartilage tissue. U.S. Pat. No. 6,042,610 to ReGen Biologics, hereby incorporated by reference, discloses the use of a device to regenerate meniscal fibrocartilage. The disclosed device comprises a bioabsorbable material made at least in part from purified collagen and glycosaminoglycans (GAG). Purified collagen and glycosaminoglycans are co-lyophilized to create a foam and then cross-linked to form the device. The device can be used to provide augmentation for a damaged meniscus. Related U.S. Pat. Nos. 5,735,903, 5,479,033, 5,306,311, 5,007,934, and 4,880,429 also disclose a meniscal augmentation device for establishing a scaffold adapted for ingrowth of meniscal fibrochondrocyts.
  • [0011]
    It is also known to use naturally occurring extracellular matrices (ECMs) to provide a scaffold for tissue repair and regeneration. One such ECM is small intestine submucosa (SIS). SIS has been described as a natural biomaterial used to repair, support, and stabilize a wide variety of anatomical defects and traumatic injuries. See, for example, Cook® Online New Release provided by Cook Biotech at “www.cookgroup.com”. The SIS material is reported to be a naturally-occurring collagenous matrix derived from porcine small intestinal submucosa that models the qualities of its host when implanted in human soft tissues. Further, it is taught that the SIS material provides a natural matrix with a three-dimensional structure and biochemical composition that attracts host cells and supports tissue remodeling. SIS products, such as Oasis material and Surgisis material, are commercially available from Cook Biotech, Bloomington, Ind.
  • [0012]
    An SIS product referred to as RESTORE Orthobiologic Implant is available from DePuy Orthopaedics, Inc. in Warsaw, Ind. The DePuy product is described for use during rotator cuff surgery, and is provided as a resorbable framework that allows the rotator cuff tendon to regenerate itself. The RESTORE Implant is derived from porcine small intestine submucosa that has been cleaned, disinfected, and sterilized. Small intestine submucosa (SIS) has been described as a naturally-occurring ECM composed primarily of collagenous proteins. Other biological molecules, such as growth factors, glycosaminoglycans, etc., have also been identified in SIS. See Hodde et al., Tissue Eng. 2(3): 209-217 (1996); Voytik-Harbin et al., J. Cell Biochem., 67:478-491 (1997); McPherson and Badylak, Tissue Eng., 4(1): 75-83 (1998); Hodde et al., Endothelium, 8(1):11-24 (2001); Hodde and Hiles, Wounds, 13(5): 195-201 (2001); Hurst and Bonner, J. Biomater. Sci. Polym. Ed., 12(11) 1267-1279 (2001); Hodde et al., Biomaterial, 23(8): 1841-1848 (2002); and Hodde, Tissue Eng., 8(2): 295-308 (2002), all of which are incorporated by reference herein. During seven years of preclinical testing in animals, there were no incidences of infection transmission form the implant to the host, and the RESTORE Implant has not decreased the systemic activity of the immune system. See Allman et al., Transplant, 17(11): 1631-1640 (2001); Allman et al., Tissue Eng., 8(1): 53-62 (2002).
  • [0013]
    While small intestine submucosa is available, other sources of submucosa are known to be effective for tissue remodeling. These sources include, but are not limited to, stomach, bladder, alimentary, respiratory, or genital submucosa, or liver basement membrane. See, e.g., U.S. Pat. Nos. 6,171,344, 6,099,567, and 5,554,389, hereby incorporated by reference. Further, while SIS is most often porcine derived, it is known that these various submucosa materials may be derived from non-porcine sources, including bovine and ovine sources. Additionally, other collagenous matrices are known, for example lamina propria and stratum compactum.
  • [0014]
    It is also known to promote cartilage growth using glycosaminoglycans (GAG), such as hyaluronic acid (HA), dermatan sulfate, heparan sulfate, chondroiton sulfates, keratin sulfate, etc. See, e.g., U.S. Pat. Nos. 6,251,876 and 6,288,043, hereby incorporated by reference. GAGs are naturally found mostly in the extracellular matrix and on the cell surface as proteoglycans. These macromolecules are secreted by cells and play a role in both signal transduction and storage of some growth factors. In addition to the biological functions, the viscoelastic properties of GAGs provide a mechanical function by providing lubrication within a joint, to decrease friction. Hyaluronic acid is a natural component of the extracellular matrix of most cartilage tissues. HA is a linear polymer made up of repeating GAG disaccharide units of D-glucuronic acid and N-acetylglycosamine in β(1-3) and β(1-4) linkages. Illustratively HA can have a molecular weight ranging from about 300,000 kDa to about 6,000,000 kDa and can be uncrosslinked, naturally crosslinked, or crosslinked using mechanical, chemical, or enzymatic methods. The effect of treating extrasynovial tendons with HA and chemically modified HA has also been studied with reference to tendon gliding resistance and tendon adhesions to surrounding tissue after repair. Momose, Amadio, Sun, Chunfeng Zhao, Zobitz, Harrington and An, “Surface Modification of Extrasynovial Tendon by Chemically Modified Hyaluronic Acid Coating,” J. Biomed. Mater. Res. 59: 219-224 (2002).
  • SUMMARY OF THE INVENTION
  • [0015]
    It has been found that the combination of a biocompatible scaffold and HA produces a synergistic effect. Healing rates and/or quality of healing is better than the healing expected from additive effects of the scaffold or HA alone. Moreover, it has been found that retention of HA at the defect site is not problematic and co-administration of the scaffold and HA does not require HA to be cross-linked to the scaffold material. Thus, the present invention provides methods for the repair of damaged or diseased cartilaginous tissue, wherein a biocompatible scaffold and HA are co-administered to the cartilaginous tissue defect.
  • [0016]
    In addition to HA, GAGs such as dermatan sulfate, heparan sulfate, chondroitin sulfate, and keratan sulfate are also expected to be usable with the present invention. As used herein, “biological lubricant” is used to identify the aforementioned materials and others such as synovial fluid and components thereof, including mucinous glycoproteins (for example lubricin), tribonectins, articular cartilage superficial zone proteins, surface-active phospholipids, and lubricating glycoproteins I, II; vitronectin; and rooster comb hyaluronate (e.g. commercially available HEALON®, (Pharmacia Corporation, Peapack, N.J.), for example, and mixtures thereof. Such materials serve both a biological and a mechanical function: they play a biological role in directly and indirectly influencing cellular behavior by being involved in signal transduction alone or in conjunction with other extracellular matrix components such as growth factors, glycoproteins, collagens etc., and a mechanical role in providing lubrication. Thus, the use of the expression “biological lubricant” is intended to encompass materials that provide some biological function (influencing cellular behavior) and some mechanical function (lubrication).
  • [0017]
    It is believed that some commercially-available biological lubricants can be used in the practice of the present invention. Examples of such commercially-available lubricants include: ARTHREASE™ high molecular weight sodium hyaluronate, available in Europe from DePuy Orthopaedics, Inc. of Warsaw, Ind.; SYNVISC® Hylan G-F 20, manufactured by Biomatrix, Inc., of Ridgefield, N.J. and distributed by Wyeth-Ayerst Pharmaceuticals of Philadelphia, Pa.; and HYLAGAN® sodium hyaluronate, available from Sanofi-Synthelabo, Inc., of New York, N.Y. The expressions “HA”, “GAG”, and “biological lubricant” are intended to encompass these materials. It should be understood that there may be other salts of hyaluronic acid that may be used in the present invention, and the expressions “HA”, “GAG”, and “biological lubricant” should be understood to encompass such salts.
  • [0018]
    The three-dimensional biologic or synthetic scaffolds may be provided in the form of a fibrous nonwoven or foam material. The scaffold preferably has interconnecting pores or voids to facilitate the transport of nutrients and/or invasion of cells into the scaffold. The interconnected voids range in size, for example, from about 20 to 400 microns, illustratively 50 to 250 microns, depending on the application. The range of the void size in the construct can be manipulated by changing process steps during construct fabrication. See Ser. No. ______ entitled “Porous Delivery Scaffold and Method” (Attorney Docket No. 265280-71207, DEP-762), already incorporated by reference. The foam optionally may be formed around a reinforcing material, for example, a knitted mesh or an ECM layer. See U.S. patent application Ser. No. 10/172,347 entitled “Hybrid Biologic-Synthetic Bioabsorbable Scaffolds” which was filed on Jun. 14, 2002, already incorporated by reference. The fibers used to make the scaffold can be made of any biocompatible material, including bioabsorbable materials such as polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), copolymers or blends thereof, or combinations of synthetic and biologic polymers. See also, Ser. No. ______ entitled “Hybrid Biologic/Synthetic Porous Extracellular Matrix Scaffolds” (Attorney Docket No. 265280-71144, DEP-751). The biologic polymers may comprise ECM, particularly comminuted ECM. In an exemplary embodiment, the fibers that comprise scaffold are formed of a polylactic acid and polyglycolic acid copolymer at a 95:5 mole ratio.
  • [0019]
    In one embodiment of the present invention, a method is provided wherein the scaffold material is implanted into the defect. The biological lubricant, which can be a GAG or HA for example, is administered separately, either at the time of surgery or via injection subsequent to closure of the incision. Optionally, a series of additional injections may be administered over a period of time. In either case, the injection may be made intra-articularly.
  • [0020]
    In another embodiment, a method is provided wherein the scaffold material and the biological lubricant are administered to the defect together. The scaffold material may be saturated with the biological lubricant at the time of surgery. Alternatively, the scaffold material may be saturated with the biological lubricant at the time of manufacture, and may be packaged together. Optionally, a series of additional injections may be administered in this method as well.
  • [0021]
    In still another embodiment, an implantable device is provided comprising a scaffold material saturated with a biological lubricant.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0022]
    [0022]FIG. 1 is a diagrammatical view showing a tibial platform with a typical meniscus structure on the platform and a portion of the meniscus removed for illustration purposes, the tibia platform being below the condyles of the femur;
  • [0023]
    [0023]FIG. 2 is a view looking down at the tibial platform and showing diagrammatically the insertion of a scaffold to replace the portion of the meniscus removed;
  • [0024]
    [0024]FIG. 3 shows the inserted scaffold in a position to be attached to the portions of the meniscus remaining after the injured portion is removed;
  • [0025]
    [0025]FIG. 4 is a sectional view taken from FIG. 3 along the lines 4-4;
  • [0026]
    [0026]FIG. 5 is a perspective view showing an open wedge-shaped device comprising an upper panel and a lower panel angularly separated to define an apex portion and a base portion;
  • [0027]
    [0027]FIG. 6 shows a wedge shaped device prior to folding with a pocket shown in imaginary lines formed in the device;
  • [0028]
    [0028]FIG. 7 shows a further step in the process in making the device shown in FIG. 6 to produce a filled, wedge-shaped device;
  • [0029]
    [0029]FIG. 8 is a top view of a ECM device used for the repair of a meniscal defect and having barbs for attachment;
  • [0030]
    [0030]FIG. 9 is a top view of a device similar to that shown in FIG. 1, except having sutures for attachment;
  • [0031]
    [0031]FIG. 10 is a perspective, partially cut-away view of a meniscus with the device of FIG. 1 inserted into the meniscus;
  • [0032]
    [0032]FIG. 11 is a cross sectional view of a cartilage repair device implanted in subchondral bone, note that the anchor is shown in elevation rather than cross section for clarity of description; and
  • [0033]
    [0033]FIG. 12 is a cross sectional view of a cartilage repair device which uses an alternative embodiment of an anchor.
  • DETAILED DESCRIPTION
  • [0034]
    While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that there is no intent to limit the invention to the particular forms disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
  • [0035]
    Referring to FIG. 1, it will be seen that a tibial platform 10 below the condyles 12 of a knee support a meniscus 11 from which an illustrative defective portion 14 is removed to leave a wedge-shaped space 16. In the removal process, the surgeon will often leave an outer rim 18 of the meniscus. The meniscus provides a large surface of articulation between the otherwise incongruent surfaces of the tibia platform or plateau and the femur condyles (such indicated at 12). The meniscus serves to reduce contact stresses and wear in the knee joint.
  • [0036]
    The portion 14 removed from the structure shown in FIG. 1 includes a portion of the original meniscus which was within the avascular zone, particularly the radially inner portion, and may include a portion of the original meniscus which was within the vascular zone.
  • [0037]
    [0037]FIG. 2 shows how a scaffold device 20 may illustratively be inserted into the space 16 to be against the outer rim 18. This illustrative scaffold 20 is shown in FIGS. 3 and 4 in position filling the space 16 and against the rim 18 left by the surgeon. FIG. 4 shows the scaffold as comprising an upper cover or upper panel 22 and a lower cover or lower panel 24. These panels 22, 24, which may illustratively be angularly related, will define an internal space 26 between the covers. Internal space 26 optionally may be filled with a biological material, a biological structure, or a synthetic structure providing a framework for regeneration of the meniscus into the space 16. Illustratively, panels 22, 24 may be made from woven or nonwoven mats of synthetic polymer or synthetic/biologic polymers. Alternatively, scaffold 20 may be constructed by forming the synthetic or synthetic/biologic polymers in a mold, or by sculpting a block of the polymer into the proper shape.
  • [0038]
    The scaffolds may comprise synthetic polymers such as polylactic acid (PLA), polyglocolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), and copolymers and blends thereof. The synthetic polymers may be provided as textiles with woven, knitted, warped knitted, nonwoven, braided, and foamed structures, and illustratively may be imbedded in ECM material, as in copending U.S. patent application Ser. No. 10/172,347 entitled “Hybrid Biologic-Synthetic Bioabsorbable Scaffolds” which was filed on Jun. 14, 2002, or may be provided as foams with or without ECM materials, as in copending U.S. patent application Ser. No. ______ entitled “Hybrid Biologic/Synthetic Porous Extracellular Matrix Scaffolds” (Attorney Docket No. 265280-71144, DEP-751). Thus, the scaffold may be made of biocompatible polymers, with or without a biologic component, and may be provided in a variety of woven, knitted, nonwoven, braided formed, or molded, or other configurations.
  • [0039]
    Scaffold 20 may be inserted, for example, in arthroscopic surgery through portals provided in the outer anterior surface of the knee opening into the knee cavity between the condyles 12 and the tibial platform 10. However, any surgical procedure to insert a device into damaged cartilage is within the scope of the present invention. Illustratively, the upper cover 22 of the scaffold 20 may serve as a bearing surface for the condyle 12 disposed thereabove and be subjected to the compression and stress forces involved in articulation of the knee. The condyle will move upon the upper surface of the cover 22.
  • [0040]
    Turning to FIGS. 5, 6 and 7, it will be seen that an illustrative device is somewhat diagrammatically illustrated. The illustrative device 30 includes an upper panel 32 and a lower panel 34 defining a wedge-shaped device having a base portion 36 and an apex portion 38. FIG. 6 suggests that the device may include a formed wedge-shaped cavity 39 (illustrated in phantom) and that the device may be folded about a fold line 40 to provide a device such as indicated at 42 in FIG. 7. While the FIG. 5 device 30 suggests an open wedge-shaped design, the device 42 in FIG. 7 suggests that, between the upper and lower panels 32, 34 a mass of biological material may be disposed. In FIG. 6, a plurality of tacks 44 are shown attached to one of the two panels of the device to be used for securing the device to surrounding tissue in the knee. The panels 32, 34 may be trimmed to the desired wedge shape.
  • [0041]
    Referring now to FIGS. 8-10, there are shown scaffolds similar to those shown in FIGS. 6-7, except that device 100 need not be wedge shaped. Scaffold 100 comprises panels 102 and 104, with a pillow 106 of biological or synthetic material shaped to fill the void in meniscus 111 left after a partial menisectomy, as illustrated in FIG. 1. The pillow is placed between panels 102 and 104. In the illustrative embodiment, pillow 106 is smaller than panels 102 and 104, and wing portions 105 of panels 102 and 104 extend beyond pillow 106.
  • [0042]
    As shown in FIG. 8, scaffold 100 may be provided with barbed darts 112 extending from wings 105. A needle or similar device would be used to push the barbed darts 112 into or through the meniscus to secure scaffold 100 to the meniscus. Barbed darts may be made of any biocompatible material sufficiently rigid to secure scaffold 100 to the meniscus. Barbed darts 112 may be provided integrally with scaffold 100 or may be added by the surgeon prior to insertion of the device.
  • [0043]
    The scaffold 100 illustrated in FIG. 9 is similar to the scaffold shown in FIG. 8, except that instead of barbed darts, the scaffold of FIG. 9 is provided with sutures 113. The scaffold of FIG. 9 may be affixed to the meniscus in a manner similar to that of the scaffold of FIG. 8. A needle or similar device would be used to push the sutures 113 through the meniscus. As illustrated in FIG. 10, the sutures may be tied together on the outside of the meniscus to form knots 120 that secure scaffold 100 in place.
  • [0044]
    While in the various embodiments discussed herein, tacks and sutures have been shown for anchoring the devices, it will be appreciated that the devices may be anchored by any other method at the choice of the surgeon.
  • [0045]
    [0045]FIGS. 11 and 12 illustrate several scaffolds that can be used in conjunction with a biological lubricant for cartilage repair. Referring now to FIG. 11, a cartilage repair device 210 is provided for repairing damaged or diseased cartilage. The device 210 includes an anchor 212 which is anchored or otherwise positioned in an opening formed in both a section of native cartilage 216 and the underlying subchondral bone 218. The anchor 212 is configured to be secured in an area from which damaged, diseased, or destroyed native cartilage and possibly bone have been removed. The anchor 212 includes an elongated central body portion 220 and a head portion 222. The body portion 220 extends downwardly from a lower surface of the head portion 222. As shown in FIG. 11, the body portion 220 may have a number of barbs 224 extending therefrom for engaging the sidewalls of the opening formed in the bone 218. In the illustrative embodiment described herein, the barbs 224 extend radially outwardly and are inclined slightly toward the head portion 222 of the anchor 212.
  • [0046]
    The cartilage repair device 210 also includes a plug 226. The plug 226 is secured to the anchor 212. Specifically, the plug 226 is secured to the upper surface of the head portion 222 of the anchor 212. The plug 226 allows for communication across the removed portion (i.e., the portion of the native cartilage 216 from which the damaged or diseased cartilage has been removed) and the adjacent healthy cartilage. As such, the plug 226 functions as a chondrogenic growth-supporting matrix for promoting a positive cellular response in an effort to achieve articular cartilage regeneration.
  • [0047]
    The anchor 212 of the cartilage repair device 210 may be constructed of numerous types of synthetic or naturally occurring materials. For example, the anchor 212 may be constructed with a bioabsorbable polymer. Examples of such polymers include: polyesters of [alpha]-hydroxycarboxylic acids, such as poly(L-lactide) (PLLA), polyglycolide (PGA); poly-p-dioxanone (PDS); polycaprolactone (PCL); and any other bioresorbable and biocompatible polymer, co-polymer or mixture of polymers or co-polymers that are commonly used in the construction of prosthetic implants. Moreover, the anchor 212 may be constructed with a naturally occurring material such as a naturally occurring ECM (e.g., SIS). In such a case, the head portion 222 and body portion 220 of the anchor 212 may be configured as monolithic structures formed from naturally occurring ECM which is cured to be rigid and hardened to facilitate attachment to the bone 218. As such, it should be appreciated that the ECM material from which the anchor 212 is fabricated is cured to produce a structure which possesses the necessary hardness and toughness to allow the anchor 212 to be driven into bone tissue (i.e., the subchondral bone 218). See U.S. patent application Ser. No. ______ entitled “Devices from Naturally Occurring Biologically Derived Materials” (Attorney Docket No. 265280-71142, DEP-748), already incorporated by reference. It should be understood that the material selected for the anchor 212 may also comprise mixtures or composites of materials. For example, the anchor 212 could comprise both a polymer and ECM material.
  • [0048]
    As mentioned above, the plug 226, which is fixed to the anchor 212, functions as a chondrogenic growth-supporting matrix for promoting vascular invasion and cellular proliferation in an effort to achieve articular cartilage regeneration. A central body 230 of the plug 226 is configured as a porous structure of biodegradable material. When anchored to a defective area of cartilage, cells can migrate into and proliferate within the plug 226, biodegrade the plug 226 while, at the same time, synthesize new and healthy tissue to heal the defective area. The plug 226 may be made out of a nonwoven or foam scaffold of synthetic or synthetic/biologic fibers with the desired porosity and material density. Specifically, the material density and/or porosity of the plug 226 may be varied to control cell migration and proliferation. The cells can migrate from adjacent tissue or from synovial fluid. The fibers from which the plug 226 is constructed also may be formed to have a structural rigidity sufficient to withstand the compression and shear stress to which the cartilage 216 is subjected. As such, the porous material from which the plug 226 is constructed should have the structural rigidity necessary to bear the forces associated with the other bone.
  • [0049]
    One particularly useful material for fabricating the plug 226 is a porous scaffold or “foam” composed of synthetic fibers or a combination of synthetic fibers and naturally occurring ECM. Both the material density and the pore size of the foam plug 226 may be varied to fit the needs of a given plug design. Such foams may be fabricated by lyophilizing (i.e., freeze-drying) the fibers suspended in water. The material density and pore size of the resultant foam may be varied by controlling, among other things, the rate of freezing of the fiber suspension and/or the amount of water or moisture content in the fiber suspension at the on-set of the freezing process. See U.S. patent application Ser. No. ______ entitled “Cartilage Repair Apparatus and Method” (Attorney Docket 265280-71143, DEP-7490 and Ser. No. ______ entitled “Porous Extracellular Matrix Scaffold and Method” (Attorney Docket 265280-71146, DEP-747), already incorporated by reference.
  • [0050]
    Referring now to FIG. 12, there is shown another embodiment of a cartilage repair device (hereinafter referred to with reference numeral 410). The cartilage repair device 410 is somewhat similar to the cartilage repair device 210. As such, the same reference numerals are used in FIG. 12 to identify components which have previously been discussed, with additional discussion thereof being unwarranted. The cartilage repair device 410 includes an anchor 412 which is used in lieu of the anchor 212 described in regard to FIG. 11. In particular, in the embodiment shown in FIG. 12, the plug 226 is positioned in an osteochondral defect 414 without the use of a bottom-mounted anchor (i.e., the anchor 212 of FIG. 11). Similarly to as described above, the plug 226 is constructed out of synthetic fibers or a combination of synthetic fibers and naturally occurring ECM (e.g., SIS) having a desired porosity and material density.
  • [0051]
    The plug 226 is retained in the hole formed in the cartilage 216 and protected from in vivo forces by an annular shaped anchor 412. The anchor 412 may be provided in many different configurations which allow it to be press fit or otherwise anchored into the subchondral bone 218. For example, as shown in FIG. 12, the anchor 412 may be “bottle cap”-shaped so as to allow the anchor 412 to be press fit or otherwise secured into an annular groove 416 formed in the subchondral bone 218. The groove may be formed and the anchor may be shaped as described and shown in Patent Cooperation Treaty publication WO 01/39694 A2, published Jun. 7, 2001 entitled “Fixation Technology”, the complete disclosure of which is incorporated by reference herein. Alternatively, the anchor 412 may be mechanically secured to the subchondral bone 218 by use of adhesive or other types of anchoring structures (e.g., barbs).
  • [0052]
    The anchor 412 of the cartilage repair device 410 may be constructed from numerous types of synthetic or naturally occurring materials. For example, the anchor 212 may be constructed with a bioabsorbable polymer such as PLLA, PGA, PDS, PCL, or any other such bioabsorbable polymer which is commonly used in the construction of prosthetic implants. Moreover, the anchor 412 may be constructed from a naturally occurring material such as a naturally occurring ECM (e.g., SIS) that is cured or otherwise fabricated to be rigid and hardened to facilitate attachment to the bone in the same manner as described above in regard to the anchor 212 and/or the plug 226 of FIG. 11.
  • [0053]
    It is expected that the teachings of the present invention may also be advantageously combined with the teachings of the following U.S. patent applications filed concurrently herewith and which are incorporated by reference herein: Ser. No. ______ entitled “Devices from Naturally Occurring Biologically Derived Materials” (Attorney Docket No. 265280-71142, DEP-748); Ser. No. ______ entitled “Unitary Surgical Device and Method” (Attorney Docket No. DEP-750); and Ser. No. ______ entitled “Porous Extracellular Matrix Scaffold and Method” (Attorney Docket No. 265280-71146, DEP-747). It is expected that the materials and devices disclosed in those patent applications can be used in the present invention.
  • [0054]
    Similarly, it is expected that other materials may be combined with the biological lubricant or with the scaffold. For example, bioactive agents, biologically-derived agents, cells, biocompatible inorganic material and/or combinations thereof may be mixed with the scaffold material or biological lubricant.
  • [0055]
    “Bioactive agents” include one or more of the following: chemotactic agents; therapeutic agents (e.g. antibiotics, steroidal and non-steroidal analgesics and anti-inflammatories, anti-rejection agents such as immunosuppressants and anti-cancer drugs); various proteins (e.g. short chain peptides, bone morphogenic proteins, glycoprotein and lipoprotein); cell attachment mediators; biologically active ligands; integrin binding sequence; ligands; various growth and/or differentiation agents (e.g. epidermal growth factor, IGF-I, IGF-II, TGF-β I-III, growth and differentiation factors, vascular endothelial growth factors, fibroblast growth factors, platelet derived growth factors, insulin derived growth factor and transforming growth factors, parathyroid hormone, parathyroid hormone related peptide, bFGF; TGFβ superfamily factors; BMP-2; BMP-4; BMP-6; BMP-12; sonic hedgehog; GDF5; GDF6; GDF8; PDGF); small molecules that affect the upregulation of specific growth factors; tenascin-C; hyaluronic acid; chondroitin sulfate; fibronectin; decorin; thromboelastin; thrombin-derived peptides; heparin-binding domains; heparin; heparan sulfate; DNA fragments; and DNA plasmids. If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these substances will have use in the present invention, and such substances should be included in the meaning of “bioactive agent” and “bioactive agents” unless expressly limited otherwise.
  • [0056]
    “Biologically derived agents” include one or more of the following: bone (autograft, allograft, and xenograft) and derivates of bone; cartilage (autograft, allograft, and xenograft), including, for example, meniscal tissue, and derivatives; ligament (autograft, allograft, and xenograft) and derivatives; derivatives of intestinal tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of stomach tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of bladder tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of alimentary tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of respiratory tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of genital tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of liver tissue (autograft, allograft, and xenograft), including for example liver basement membrane; derivatives of skin tissue; platelet rich plasma (PRP), platelet poor plasma, bone marrow aspirate, demineralized bone matrix, insulin derived growth factor, whole blood, fibrin and blood clot. Purified ECM and other collagen sources are also intended to be included within “biologically derived agents.” If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these substances will have use in the present invention, and such substances should be included in the meaning of “biologically-derived agent” and “biologically-derived agents” unless expressly limited otherwise.
  • [0057]
    “Biologically derived agents” also include bioremodelable collageneous tissue matrices. The expressions “bioremodelable collagenous tissue matrix” and “naturally occurring bioremodelable collageneous tissue matrix” include matrices derived from native tissue selected from the group consisting of skin, artery, vein, pericardium, heart valve, dura mater, ligament, bone, cartilage, bladder, liver, stomach, fascia and intestine, tendon, whatever the source. Although “naturally occurring bioremodelable collageneous tissue matrix” is intended to refer to matrix material that has been cleaned, processed, sterilized, and optionally crosslinked, it is not within the definition of a naturally occurring bioremodelable collageneous tissue matrix to purify the natural fibers and reform a matrix material from purified natural fibers. The term “bioremodelable collageneous tissue matrices” includes “extracellular matrices” within its definition.
  • [0058]
    “Cells” include one or more of the following: chondrocytes; fibrochondrocytes; osteocytes; osteoblasts; osteoclasts; synoviocytes; bone marrow cells; mesenchymal cells; stromal cells; stem cells; embryonic stem cells; precursor cells derived from adipose tissue; peripheral blood progenitor cells; stem cells isolated from adult tissue; genetically transformed cells; a combination of chondrocytes and other cells; a combination of osteocytes and other cells; a combination of synoviocytes and other cells; a combination of bone marrow cells and other cells; a combination of mesenchymal cells and other cells; a combination of stromal cells and other cells; a combination of stem cells and other cells; a combination of embryonic stem cells and other cells; a combination of precursor cells isolated from adult tissue and other cells; a combination of peripheral blood progenitor cells and other cells; a combination of stem cells isolated from adult tissue and other cells; and a combination of genetically transformed cells and other cells. If other cells are found to have therapeutic value in the orthopaedic field, it is anticipated that at least some of these cells will have use in the present invention, and such cells should be included within the meaning of “cell” and “cells” unless expressly limited otherwise. Illustratively, in one example of embodiments that are to be seeded with living cells such as chondrocytes, a sterilized implant may be subsequently seeded with living cells and packaged in an appropriate medium for the cell type used. For example, a cell culture medium comprising Dulbecco's Modified Eagles Medium (DMEM) can be used with standard additives such as non-essential amino acids, glucose, ascorbic acid, sodium pyruvate, fungicides, antibiotics, etc., in concentrations deemed appropriate for cell type, shipping conditions, etc.
  • [0059]
    “Biocompatible inorganic materials” include materials such as hydroxyapatite, all calcium phosphates, alpha-tricalcium phosphate, beta-tricalcium phosphate, calcium carbonate, barium carbonate, calcium sulfate, barium sulfate, polymorphs of calcium phosphate, sintered and non-sintered ceramic particles, and combinations of such materials. If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these substances will have use in the present invention, and such substances should be included in the meaning of “biocompatible inorganic material” and “biocompatible inorganic materials” unless expressly limited otherwise.
  • [0060]
    It is expected that various combinations of bioactive agents, biologically derived agents, cells, biological lubricants, biocompatible inorganic materials, biocompatible polymers can be used with the scaffolds and methods of the present invention.
  • [0061]
    It is expected that standard disinfection and sterilization techniques may be used with the products of the present invention.
  • EXAMPLE 1
  • [0062]
    A defect in goat articular cartilage was repaired with a device as illustrated in FIG. 11. HA was applied post-operatively after repairing the defect with a synthetic scaffold according to FIG. 11. When compared to cartilage defects repaired without HA, the tissue repaired with both the device and HA appeared to be more mature, with a whiter, more hyaline-like appearance. Also, the repaired tissue that is treated with both the device and HA showed evidence of less severe degradative changes than is seen in the non-HA treated animals.
  • [0063]
    Although the examples all relate to use of HA, it is expected that other biological lubricants will provide similar benefits. It should be understood that the nature of the biological lubricant and the means of administering the biological lubricant can affect the quality of lubrication provided and can also affect the biological effects observed. For example, although a biological lubricant such as HA can be cross-linked to the matrix and still provide adequate lubrication, some GAG sulfates (e.g. chondroitin sulfate) can be expected to be less effective, or ineffective, as a lubricant if cross-linked or co-lyophilized with the underlying matrix, yet still be used for its biological effects. For some biological lubricants, it will be desirable to provide the biological lubricant in a fluidized form to maximize lubrication. In addition, different materials identified as falling within the definition of biological lubricants can be expected to have different efficacies as lubricants and different biological efficacies. Of the identified biological lubricants, those sharing properties (e.g. viscosity) similar to those of HA may provide greater clinical benefit as lubricants. Of the identified biological lubricants, those decreasing the coefficient of friction between the implant and healthy cartilage, compared to the case without the lubricant, are expected to be beneficial, and particularly those biological lubricants providing a reduced coefficient of friction for an extended period time. Other of the identified biological lubricants may provide greater clinical benefit as biologic agents. It should also be understood that materials identified as biological lubricants and the means of administering the material may be combined in various ways to take advantage of the properties of each and to maximize the clinical benefits of administering the various materials. Although the invention has been described in detail with reference to certain preferred embodiments, variations and modifications exist within the scope and spirit of the invention as described and defined in the following claims.
Citations de brevets
Brevet cité Date de dépôt Date de publication Déposant Titre
US3272204 *22 sept. 196513 sept. 1966Ethicon IncAbsorbable collagen prosthetic implant with non-absorbable reinforcing strands
US4105034 *10 juin 19778 août 1978Ethicon, Inc.Poly(alkylene oxalate) absorbable coating for sutures
US4140678 *13 juin 197720 févr. 1979Ethicon, Inc.Synthetic absorbable surgical devices of poly(alkylene oxalates)
US4141087 *19 janv. 197727 févr. 1979Ethicon, Inc.Isomorphic copolyoxalates and sutures thereof
US4205399 *26 mai 19783 juin 1980Ethicon, Inc.Synthetic absorbable surgical devices of poly(alkylene oxalates)
US4206511 *17 mai 19783 juin 1980Mannesmann AktiengesellschaftLocating a welding seam
US4610397 *27 oct. 19839 sept. 1986Urschel Laboratories IncorporatedComminuting equipment
US4669473 *6 sept. 19852 juin 1987Acufex Microsurgical, Inc.Surgical fastener
US4736372 *10 sept. 19865 avr. 1988Siemens AktiengesellschaftMethod and apparatus of transmission for a digital signal
US4741330 *4 avr. 19863 mai 1988Hayhurst John OMethod and apparatus for anchoring and manipulating cartilage
US4750492 *27 févr. 198514 juin 1988Richards Medical CompanyAbsorbable suture apparatus, method and installer
US4846835 *15 juin 198711 juil. 1989Grande Daniel ATechnique for healing lesions in cartilage
US4956179 *2 juil. 198711 sept. 1990Astra Lakemedel AktiebolagAntibacterial combination of penicillin and cephalosporin
US5102421 *14 juin 19907 avr. 1992Wm. E. Anpach, IIISuture anchor and method of forming
US5350583 *3 nov. 199227 sept. 1994Terumo Kabushiki KaishaCell-penetrable medical material and artificial skin
US5447940 *27 juil. 19945 sept. 1995Johnson & Johnson Medical, Inc.Absorbable composite materials for use in the treatment of periodontal disease
US5514181 *29 sept. 19947 mai 1996Johnson & Johnson Medical, Inc.Absorbable structures for ligament and tendon repair
US5520691 *13 déc. 199428 mai 1996Branch; Thomas P.Method and apparatus for re-approximating tissue
US5545178 *21 oct. 199413 août 1996Kensey Nash CorporationSystem for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating
US5595621 *7 juin 199521 janv. 1997Johnson & Johnson Medical, Inc.Method of making absorbable structures for ligament and tendon repair
US5595751 *8 févr. 199621 janv. 1997Ethicon, Inc.Absorbable polyoxaesters containing amines and/or amido groups
US5597579 *5 mars 199628 janv. 1997Ethicon, Inc.Blends of absorbable polyoxaamides
US5607687 *5 mars 19964 mars 1997Ethicon, Inc.Polymer blends containing absorbable polyoxaesters
US5618552 *5 mars 19968 avr. 1997Ethicon, Inc.Absorbable polyoxaesters
US5620698 *14 juin 199615 avr. 1997Ethicon, Inc.Blends of absorbable polyoxaesters containing amines and/or amido groups
US5626614 *22 déc. 19956 mai 1997Applied Medical Resources CorporationT-anchor suturing device and method for using same
US5630824 *1 juin 199420 mai 1997Innovasive Devices, Inc.Suture attachment device
US5645850 *7 août 19968 juil. 1997Ethicon, Inc.Blending containing absorbable polyoxaamides
US5648088 *5 mars 199615 juil. 1997Ethicon, Inc.Blends of absorbable polyoxaesters containing amines and/or amide groups
US5660225 *13 nov. 199526 août 1997Saffran; Bruce NathanMethod of fracture treatment by restraining macromolecules or macromolecular aggregates adjacent to damaged tissues
US5725556 *15 déc. 199510 mars 1998M & R Medical, Inc.Suture locking apparatus
US5735897 *2 janv. 19977 avr. 1998Scimed Life Systems, Inc.Intravascular stent pump
US5736372 *16 avr. 19907 avr. 1998Massachusetts Institute Of TechnologyBiodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US5759208 *29 févr. 19962 juin 1998The Procter & Gamble CompanyLaundry detergent compositions containing silicone emulsions
US5773577 *2 mars 199530 juin 1998Protein Polymer TechnologiesProducts comprising substrates capable of enzymatic cross-linking
US5855610 *19 mai 19955 janv. 1999Children's Medical Center CorporationEngineering of strong, pliable tissues
US5859150 *5 nov. 199712 janv. 1999Ethicon, Inc.Prepolymers of absorbable polyoxaesters
US5861004 *29 août 199719 janv. 1999Kensey Nash CorporationHemostatic puncture closure system including closure locking means and method of use
US5863551 *16 oct. 199626 janv. 1999Organogel Canada LteeImplantable polymer hydrogel for therapeutic uses
US5866165 *15 janv. 19972 févr. 1999Orquest, Inc.Collagen-polysaccharide matrix for bone and cartilage repair
US5891558 *21 nov. 19966 avr. 1999Tissue Engineering, Inc.Biopolymer foams for use in tissue repair and reconstruction
US5893888 *6 sept. 199413 avr. 1999Tissue Engineering, Inc.Method and construct for producing graft tissue from extracellular matrix
US5899939 *21 janv. 19984 mai 1999Osteotech, Inc.Bone-derived implant for load-supporting applications
US5906997 *17 juin 199725 mai 1999Fzio Med, Inc.Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US5939323 *28 mai 199717 août 1999Brown UniversityHyaluronan based biodegradable scaffolds for tissue repair
US6010525 *1 août 19974 janv. 2000Peter M. BonuttiMethod and apparatus for securing a suture
US6017301 *13 févr. 199825 janv. 2000Fziomed, Inc.Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6034140 *13 févr. 19987 mars 2000Fziomed, Inc.Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6066160 *23 nov. 199823 mai 2000Quickie LlcPassive knotless suture terminator for use in minimally invasive surgery and to facilitate standard tissue securing
US6077989 *15 mai 199720 juin 2000Kandel; RitaResorbable implant biomaterial made of condensed calcium phosphate particles
US6110212 *7 févr. 199729 août 2000Kenton W. GregoryElastin and elastin-based materials
US6197296 *29 mars 19946 mars 2001National Heart Research FundTissue equivalents
US6214048 *30 mai 199510 avr. 2001Matsumoto Dental CollegeBone substitute product and method of producing the same
US6242247 *2 juin 19975 juin 2001Sulzer Orthopedics Ltd.Method for making cartilage and implants
US6258124 *10 mai 199910 juil. 2001C. R. Bard, Inc.Prosthetic repair fabric
US6264702 *22 juil. 199824 juil. 2001Sofradim ProductionComposite prosthesis for preventing post-surgical adhesions
US6265333 *1 déc. 199824 juil. 2001Board Of Regents, University Of Nebraska-LincolnDelamination resistant composites prepared by small diameter fiber reinforcement at ply interfaces
US6267957 *20 janv. 199931 juil. 2001Howard GreenAttaching agents to tissue with transglutaminase and a transglutaminase substrate
US6270530 *9 juin 20007 août 2001C.R. Bard, Inc.Prosthetic repair fabric
US6280473 *23 févr. 199928 août 2001Macropore, Inc.Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US6280474 *27 juil. 199928 août 2001Neucoll, Inc.Devices for tissue repair and methods for preparation and use thereof
US6358284 *2 juin 199919 mars 2002Med Institute, Inc.Tubular grafts from purified submucosa
US6373221 *27 déc. 200016 avr. 2002Kabushiki Kaisha Toyoda Jidoshokki SeisakushoCharger coupling
US6387693 *18 avr. 200114 mai 2002Sulzer Orthopedics Ltd.Method for producing cartilage tissue and implants for repairing enchondral and osteochondral defects as well as arrangement for carrying out the method
US6402766 *26 févr. 200111 juin 2002Ethicon, Inc.Graft fixation device combination
US6423073 *26 févr. 200123 juil. 2002Ethicon, Inc.Instrument for inserting graft fixation device
US6436110 *26 févr. 200120 août 2002Ethicon, Inc.Method of securing a graft using a graft fixation device
US6440444 *24 juil. 200127 août 2002Osteotech, Inc.Load bearing osteoimplant and method of repairing bone using the same
US6508821 *28 janv. 200021 janv. 2003Depuy Orthopaedics, Inc.Soft tissue repair material fixation apparatus and method
US6517564 *2 févr. 200011 févr. 2003Arthrex, Inc.Bioabsorbable tissue tack with oval-shaped head and method of tissue fixation using same
US6566345 *26 avr. 200120 mai 2003Fziomed, Inc.Polyacid/polyalkylene oxide foams and gels and methods for their delivery
US6572650 *4 juin 19993 juin 2003Organogenesis Inc.Bioengineered vascular graft support prostheses
US6592623 *31 août 199915 juil. 2003Virginia Commonwealth University Intellectual Property FoundationEngineered muscle
US6692499 *2 juil. 199717 févr. 2004Linvatec Biomaterials OySurgical fastener for tissue treatment
US6840962 *25 sept. 200011 janv. 2005Massachusetts Institute Of TechnologyTissue engineered tendons and ligaments
US6869938 *27 déc. 199922 mars 2005Fziomed, Inc.Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US6989034 *31 mai 200224 janv. 2006Ethicon, Inc.Attachment of absorbable tissue scaffolds to fixation devices
US20010002446 *23 janv. 200131 mai 2001Plouhar Pamela L.Tissue graft construct for replacement of cartilaginous structures
US20020031551 *6 août 200114 mars 2002Peterson Dale R.Bioerodable polymeric adhesives for tissue repair
US20020034533 *19 sept. 200121 mars 2002Peterson Dale R.Bioerodable polymeric adhesives for tissue repair
US20020038151 *30 juil. 200128 mars 2002Plouhar Pamela L.Reinforced small intestinal submucosa (SIS)
US20020052628 *24 mai 20012 mai 2002Bowman Steven M.Graft fixation device and method
US20020095157 *24 janv. 200218 juil. 2002Bowman Steven M.Graft fixation device combination
US20030014126 *28 juin 200216 janv. 2003Patel Umesh H.Graft prosthesis devices containing renal capsule collagen
US20030021827 *15 juil. 200230 janv. 2003Prasanna MalaviyaHybrid biologic/synthetic porous extracellular matrix scaffolds
US20030023316 *14 juin 200230 janv. 2003Brown Laura JeanHybrid biologic-synthetic bioabsorable scaffolds
US20030032961 *15 juil. 200213 févr. 2003Pelo Mark JosephDevices from naturally occurring biologically derived materials
US20030033022 *15 juil. 200213 févr. 2003Plouhar Pamela LynnCartilage repair and regeneration device and method
US20030036797 *15 juil. 200220 févr. 2003Prasanna MalaviyaMeniscus regeneration device and method
US20030036801 *15 juil. 200220 févr. 2003Schwartz Herbert E.Cartilage repair apparatus and method
US20030044444 *15 juil. 20026 mars 2003Prasanna MalaviyaPorous extracellular matrix scaffold and method
US20030049299 *15 juil. 200213 mars 2003Prasanna MalaviyaPorous delivery scaffold and method
US20030078617 *15 juil. 200224 avr. 2003Schwartz Herbert E.Unitary surgical device and method
US20040059431 *5 sept. 200325 mars 2004Plouhar Pamela L.Reinforced small intestinal submucosa
US20040143344 *29 déc. 200322 juil. 2004Prasanna MalaviyaImplantable tissue repair device and method
US20040166169 *15 juil. 200226 août 2004Prasanna MalaviyaPorous extracellular matrix scaffold and method
US20050027307 *15 juil. 20023 févr. 2005Schwartz Herbert EugeneUnitary surgical device and method
USRE34021 *13 nov. 19894 août 1992Abbott LaboratoriesPercutaneous fixation of hollow organs
Référencé par
Brevet citant Date de dépôt Date de publication Déposant Titre
US753119025 mai 200512 mai 2009Biomet Manufacturing Corp.Porous ceramic structure containing biologics
US760117612 oct. 200413 oct. 2009Tecres S.P.A.Disposable articulated spacing device for surgical treatment of joints of the human body
US765875129 sept. 20069 févr. 2010Biomet Sports Medicine, LlcMethod for implanting soft tissue
US76662308 déc. 200323 févr. 2010Depuy Products, Inc.Implant device for cartilage regeneration in load bearing articulation regions
US77492503 févr. 20066 juil. 2010Biomet Sports Medicine, LlcSoft tissue repair assembly and associated method
US778086019 mai 200824 août 2010Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US778533228 oct. 200531 août 2010Depuy Products, Inc.Method of delivering therapeutic implant
US779908910 oct. 200621 sept. 2010Depuy Orthopaedics, Inc.Reinforced small intestinal submucosa
US780627611 avr. 20085 oct. 2010Hanuman, LlcBuoy suspension fractionation system
US78159267 juil. 200619 oct. 2010Musculoskeletal Transplant FoundationImplant for articular cartilage repair
US7819918 *29 déc. 200326 oct. 2010Depuy Products, Inc.Implantable tissue repair device
US7820638 *7 août 200326 oct. 2010Arthrex, Inc.Method of applying hyaluronic acid to implant or graft to enhance lubricity and cellular density
US782470125 févr. 20032 nov. 2010Ethicon, Inc.Biocompatible scaffold for ligament or tendon repair
US783256625 mai 200616 nov. 2010Biomet Biologics, LlcMethod and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US783774024 janv. 200723 nov. 2010Musculoskeletal Transplant FoundationTwo piece cancellous construct for cartilage repair
US783788429 déc. 200823 nov. 2010Hanuman, LlcMethods and apparatus for isolating platelets from blood
US784549925 mai 20067 déc. 2010Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US78578309 oct. 200728 déc. 2010Biomet Sports Medicine, LlcSoft tissue repair and conduit device
US785785128 oct. 200528 déc. 2010Depuy Products, Inc.Implant system with sizing templates
US787144011 déc. 200618 janv. 2011Depuy Products, Inc.Unitary surgical device and method
US787529629 nov. 200725 janv. 2011Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US790145716 mai 20038 mars 2011Musculoskeletal Transplant FoundationCartilage allograft plug
US79014615 déc. 20038 mars 2011Ethicon, Inc.Viable tissue repair implants and methods of use
US79059036 nov. 200715 mars 2011Biomet Sports Medicine, LlcMethod for tissue fixation
US790590415 janv. 200815 mars 2011Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US790985115 janv. 200822 mars 2011Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US79145395 déc. 200529 mars 2011Biomet Sports Medicine, LlcTissue fixation device
US791468919 mai 200829 mars 2011Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US791480815 juil. 200229 mars 2011Depuy Products, Inc.Hybrid biologic/synthetic porous extracellular matrix scaffolds
US795965022 août 200814 juin 2011Biomet Sports Medicine, LlcAdjustable knotless loops
US799272511 avr. 20089 août 2011Biomet Biologics, LlcBuoy suspension fractionation system
US8012205 *15 juil. 20026 sept. 2011Depuy Products, Inc.Cartilage repair and regeneration device
US801686728 oct. 200413 sept. 2011Depuy Mitek, Inc.Graft fixation device and method
US802589615 juil. 200227 sept. 2011Depuy Products, Inc.Porous extracellular matrix scaffold and method
US803409021 mars 200611 oct. 2011Biomet Sports Medicine, LlcTissue fixation device
US804832111 août 20101 nov. 2011Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US80625346 déc. 201022 nov. 2011Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US808813029 mai 20093 janv. 2012Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US809252915 juil. 200210 janv. 2012Depuy Products, Inc.Meniscus regeneration device
US811883622 août 200821 févr. 2012Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US81190134 oct. 201021 févr. 2012Hanuman, LlcMethod of separating a selected component from a multiple component material
US81286409 août 20066 mars 2012Ivy Sports Medicine LLCSystem and method for all-inside suture fixation for implant attachment and soft tissue repair
US812865822 août 20086 mars 2012Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to bone
US813735425 avr. 200720 mars 2012Biomet Sports Medicine, LlcLocalized cartilage defect therapy
US813738222 août 200820 mars 2012Biomet Sports Medicine, LlcMethod and apparatus for coupling anatomical features
US813768620 avr. 200420 mars 2012Depuy Mitek, Inc.Nonwoven tissue scaffold
US813770229 déc. 201020 mars 2012Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US816318425 mars 201124 avr. 2012Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US818747722 nov. 201029 mai 2012Hanuman, LlcMethods and apparatus for isolating platelets from blood
US822145427 oct. 200917 juil. 2012Biomet Sports Medicine, LlcApparatus for performing meniscus repair
US822150024 juil. 200817 juil. 2012Musculoskeletal Transplant FoundationCartilage allograft plug
US822178029 juin 200617 juil. 2012Depuy Mitek, Inc.Nonwoven tissue scaffold
US822671530 juin 200324 juil. 2012Depuy Mitek, Inc.Scaffold for connective tissue repair
US82316546 mai 201131 juil. 2012Biomet Sports Medicine, LlcAdjustable knotless loops
US825199812 févr. 200828 août 2012Biomet Sports Medicine, LlcChondral defect repair
US827310622 déc. 201025 sept. 2012Biomet Sports Medicine, LlcSoft tissue repair and conduit device
US829292111 mars 201123 oct. 2012Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US82929681 févr. 201123 oct. 2012Musculoskeletal Transplant FoundationCancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US829826222 juin 200930 oct. 2012Biomet Sports Medicine, LlcMethod for tissue fixation
US830360430 sept. 20096 nov. 2012Biomet Sports Medicine, LlcSoft tissue repair device and method
US83139543 avr. 200920 nov. 2012Biomet Biologics, LlcAll-in-one means of separating blood components
US83178257 avr. 200927 nov. 2012Biomet Sports Medicine, LlcSoft tissue conduit device and method
US83280244 août 201111 déc. 2012Hanuman, LlcBuoy suspension fractionation system
US833752511 mars 201125 déc. 2012Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US833753715 juil. 200225 déc. 2012Depuy Products, Inc.Device from naturally occurring biologically derived materials
US833771127 févr. 200925 déc. 2012Biomet Biologics, LlcSystem and process for separating a material
US834322727 mai 20101 janv. 2013Biomet Manufacturing Corp.Knee prosthesis assembly with ligament link
US836111322 juin 200929 janv. 2013Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US836678714 juin 20025 févr. 2013Depuy Products, Inc.Hybrid biologic-synthetic bioabsorbable scaffolds
US84092531 juil. 20102 avr. 2013Biomet Sports Medicine, LlcSoft tissue repair assembly and associated method
US843555124 juil. 20097 mai 2013Musculoskeletal Transplant FoundationCancellous construct with support ring for repair of osteochondral defects
US844956115 févr. 200728 mai 2013Depuy Mitek, LlcGraft fixation device combination
US849697027 févr. 201230 juil. 2013Depuy Mitek, LlcConformable tissue repair implant capable of injection delivery
US850081827 mai 20106 août 2013Biomet Manufacturing, LlcKnee prosthesis assembly with ligament link
US850659725 oct. 201113 août 2013Biomet Sports Medicine, LlcMethod and apparatus for interosseous membrane reconstruction
US855114013 juil. 20118 oct. 2013Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to bone
US85626452 mai 201122 oct. 2013Biomet Sports Medicine, LlcMethod and apparatus for forming a self-locking adjustable loop
US856264729 oct. 201022 oct. 2013Biomet Sports Medicine, LlcMethod and apparatus for securing soft tissue to bone
US856760919 avr. 201129 oct. 2013Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US857423519 mai 20115 nov. 2013Biomet Sports Medicine, LlcMethod for trochanteric reattachment
US857423828 oct. 20055 nov. 2013Depuy Mitek, LlcInstruments, kit and method for suture management
US859139112 avr. 201026 nov. 2013Biomet Biologics, LlcMethod and apparatus for separating a material
US859647020 févr. 20123 déc. 2013Hanuman, LlcBuoy fractionation system
US85973273 nov. 20103 déc. 2013Biomet Manufacturing, LlcMethod and apparatus for sternal closure
US860334622 sept. 201110 déc. 2013Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US860877721 oct. 201117 déc. 2013Biomet Sports MedicineMethod and apparatus for coupling soft tissue to a bone
US863256920 déc. 201221 janv. 2014Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US863706621 sept. 201028 janv. 2014Depuy Mitek, LlcBiocompatible scaffold for ligament or tendon repair
US8641775 *1 févr. 20114 févr. 2014Depuy Mitek, LlcViable tissue repair implants and methods of use
US86521712 mai 201118 févr. 2014Biomet Sports Medicine, LlcMethod and apparatus for soft tissue fixation
US86521726 juil. 201118 févr. 2014Biomet Sports Medicine, LlcFlexible anchors for tissue fixation
US86729688 févr. 201018 mars 2014Biomet Sports Medicine, LlcMethod for implanting soft tissue
US86729697 oct. 201118 mars 2014Biomet Sports Medicine, LlcFracture fixation device
US869125916 nov. 20058 avr. 2014Depuy Mitek, LlcReinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US87216845 mars 201213 mai 2014Biomet Sports Medicine, LlcMethod and apparatus for coupling anatomical features
US87713165 mars 20128 juil. 2014Biomet Sports Medicine, LlcMethod and apparatus for coupling anatomical features
US877135217 mai 20118 juil. 2014Biomet Sports Medicine, LlcMethod and apparatus for tibial fixation of an ACL graft
US877795616 août 201215 juil. 2014Biomet Sports Medicine, LlcChondral defect repair
US878347025 mai 201222 juil. 2014Biomet Biologics, LlcMethod and apparatus for producing autologous thrombin
US8801586 *20 déc. 201212 août 2014Biomet Biologics, LlcSystem and process for separating a material
US880178327 mai 201012 août 2014Biomet Sports Medicine, LlcProsthetic ligament system for knee joint
US88083097 févr. 200619 août 2014Ivy Sports Medicine, LlcSystem and method for all-inside suture fixation for implant attachment and soft tissue repair
US880855115 nov. 201019 août 2014Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US884064517 févr. 201223 sept. 2014Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US88950458 mai 201225 nov. 2014Depuy Mitek, LlcMethod of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US890031419 déc. 20122 déc. 2014Biomet Manufacturing, LlcMethod of implanting a prosthetic knee joint assembly
US890611014 sept. 20109 déc. 2014Musculoskeletal Transplant FoundationTwo piece cancellous construct for cartilage repair
US89323315 mars 201213 janv. 2015Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to bone
US89366213 nov. 201120 janv. 2015Biomet Sports Medicine, LlcMethod and apparatus for forming a self-locking adjustable loop
US89505861 juil. 201310 févr. 2015Hanuman LlcMethods and apparatus for isolating platelets from blood
US896836417 mai 20113 mars 2015Biomet Sports Medicine, LlcMethod and apparatus for fixation of an ACL graft
US899286215 nov. 201231 mars 2015Biomet Biologics, LlcAll-in-one means of separating blood components
US899894916 août 20067 avr. 2015Biomet Sports Medicine, LlcSoft tissue conduit device
US90052874 nov. 201314 avr. 2015Biomet Sports Medicine, LlcMethod for bone reattachment
US901180016 juil. 200921 avr. 2015Biomet Biologics, LlcMethod and apparatus for separating biological materials
US901738110 avr. 200728 avr. 2015Biomet Sports Medicine, LlcAdjustable knotless loops
US90786448 mars 201014 juil. 2015Biomet Sports Medicine, LlcFracture fixation device
US911395423 mars 201225 août 2015DePuy Synthes Products, Inc.Coordinate instrument set
US91143349 déc. 201325 août 2015Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US91386642 déc. 201322 sept. 2015Biomet Biologics, LlcBuoy fractionation system
US914926710 nov. 20116 oct. 2015Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US917365122 oct. 20123 nov. 2015Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US92113628 juin 201215 déc. 2015Depuy Mitek, LlcScaffold for connective tissue repair
US92160788 mai 201322 déc. 2015Biomet Sports Medicine, LlcMethod and apparatus for tibial fixation of an ACL graft
US923927628 oct. 201319 janv. 2016Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US92592173 janv. 201216 févr. 2016Biomet Manufacturing, LlcSuture Button
US926561012 juil. 201023 févr. 2016Peter ForsellImplantable medical device for lubrication of a synovial joint and method for implanting the device
US927171314 nov. 20111 mars 2016Biomet Sports Medicine, LlcMethod and apparatus for tensioning a suture
US9277999 *26 févr. 20108 mars 2016University of Pittsburgh—of the Commonwealth System of Higher EducationJoint bioscaffolds
US93142411 févr. 201319 avr. 2016Biomet Sports Medicine, LlcApparatus for coupling soft tissue to a bone
US931434026 juin 201419 avr. 2016University of Pittsburgh—of the Commonwealth System of Higher EducationJoint bioscaffolds
US935799119 déc. 20127 juin 2016Biomet Sports Medicine, LlcMethod and apparatus for stitching tendons
US93579921 févr. 20137 juin 2016Biomet Sports Medicine, LlcMethod for coupling soft tissue to a bone
US93703508 mars 201321 juin 2016Biomet Sports Medicine, LlcApparatus for coupling soft tissue to a bone
US93810138 mars 20135 juil. 2016Biomet Sports Medicine, LlcMethod for coupling soft tissue to a bone
US94026162 mars 20122 août 2016Ivy Sports Medicine, LlcSystem and method for all-inside suture fixation for implant attachment and soft tissue repair
US940262124 sept. 20122 août 2016Biomet Sports Medicine, LLC.Method for tissue fixation
US941483314 févr. 201316 août 2016Biomet Sports Medicine, LlcSoft tissue repair assembly and associated method
US94149255 août 201316 août 2016Biomet Manufacturing, LlcMethod of implanting a knee prosthesis assembly with a ligament link
US94334076 janv. 20166 sept. 2016Biomet Manufacturing, LlcMethod of implanting a bone fixation assembly
US944582712 août 201320 sept. 2016Biomet Sports Medicine, LlcMethod and apparatus for intraosseous membrane reconstruction
US94684333 nov. 201118 oct. 2016Biomet Sports Medicine, LlcMethod and apparatus for forming a self-locking adjustable loop
US948621114 mars 20148 nov. 2016Biomet Sports Medicine, LlcMethod for implanting soft tissue
US94865588 mai 20088 nov. 2016Locate Therapeutics LimitedPorous matrix
US949215828 janv. 201315 nov. 2016Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US94982047 juil. 201422 nov. 2016Biomet Sports Medicine, LlcMethod and apparatus for coupling anatomical features
US95044605 oct. 201229 nov. 2016Biomet Sports Medicine, LLC.Soft tissue repair device and method
US951081915 mars 20136 déc. 2016Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US951082112 mai 20146 déc. 2016Biomet Sports Medicine, LlcMethod and apparatus for coupling anatomical features
US951117122 nov. 20106 déc. 2016Depuy Mitek, LlcBiocompatible scaffolds with tissue fragments
US953277716 déc. 20133 janv. 2017Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US953309021 nov. 20133 janv. 2017Biomet Biologics, LlcMethod and apparatus for separating a material
US953899825 oct. 201110 janv. 2017Biomet Sports Medicine, LlcMethod and apparatus for fracture fixation
US953900316 oct. 201310 janv. 2017Biomet Sports Medicine, LLC.Method and apparatus for forming a self-locking adjustable loop
US955624310 oct. 201331 janv. 2017Biomet Biologies, LLCMethods for making cytokine compositions from tissues using non-centrifugal methods
US956102515 mars 20137 févr. 2017Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US957265522 sept. 201421 févr. 2017Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US960359117 févr. 201428 mars 2017Biomet Sports Medicine, LlcFlexible anchors for tissue fixation
US961582230 mai 201411 avr. 2017Biomet Sports Medicine, LlcInsertion tools and method for soft anchor
US9616093 *30 janv. 201311 avr. 2017NuTech Medical, Inc.Placental membrane preparation and methods of making and using same
US962273620 janv. 201418 avr. 2017Biomet Sports Medicine, LlcSoft tissue repair device and associated methods
US96426612 déc. 20139 mai 2017Biomet Sports Medicine, LlcMethod and Apparatus for Sternal Closure
US964295627 août 20129 mai 2017Biomet Biologics, LlcApparatus and method for separating and concentrating fluids containing multiple components
US964957910 déc. 201216 mai 2017Hanuman LlcBuoy suspension fractionation system
US968194011 août 201420 juin 2017Biomet Sports Medicine, LlcLigament system for knee joint
US97002913 juin 201411 juil. 2017Biomet Sports Medicine, LlcCapsule retractor
US970172824 juil. 201511 juil. 2017Biomet Biologics, LlcMethods and compositions for delivering interleukin-1 receptor antagonist
US970194019 déc. 201411 juil. 2017Histogenics CorporationCell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US971906311 août 20141 août 2017Biomet Biologics, LlcSystem and process for separating a material
US972409016 oct. 20138 août 2017Biomet Manufacturing, LlcMethod and apparatus for attaching soft tissue to bone
US97571198 mars 201312 sept. 2017Biomet Sports Medicine, LlcVisual aid for identifying suture limbs arthroscopically
US976365617 févr. 201419 sept. 2017Biomet Sports Medicine, LlcMethod and apparatus for soft tissue fixation
US978887617 mars 201417 oct. 2017Biomet Sports Medicine, LlcFracture fixation device
US980162012 janv. 201531 oct. 2017Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to bone
US98017082 déc. 201531 oct. 2017Biomet Sports Medicine, LlcMethod and apparatus for coupling soft tissue to a bone
US20030023316 *14 juin 200230 janv. 2003Brown Laura JeanHybrid biologic-synthetic bioabsorable scaffolds
US20030033022 *15 juil. 200213 févr. 2003Plouhar Pamela LynnCartilage repair and regeneration device and method
US20030036797 *15 juil. 200220 févr. 2003Prasanna MalaviyaMeniscus regeneration device and method
US20030044444 *15 juil. 20026 mars 2003Prasanna MalaviyaPorous extracellular matrix scaffold and method
US20030078617 *15 juil. 200224 avr. 2003Schwartz Herbert E.Unitary surgical device and method
US20040054417 *9 avr. 200118 mars 2004Renzo SoffiatiDisposable articulated spacing device for surgical treatment of joints of the human body
US20040059431 *5 sept. 200325 mars 2004Plouhar Pamela L.Reinforced small intestinal submucosa
US20040143344 *29 déc. 200322 juil. 2004Prasanna MalaviyaImplantable tissue repair device and method
US20040166169 *15 juil. 200226 août 2004Prasanna MalaviyaPorous extracellular matrix scaffold and method
US20040180822 *7 août 200316 sept. 2004Grafton R. DonaldMethod of applying hyaluronic acid to implant or graft to enhance lubricity and cellular density
US20040220574 *15 juil. 20024 nov. 2004Pelo Mark JosephDevice from naturally occuring biologically derived materials
US20040230303 *16 mai 200318 nov. 2004Gomes Katherine A.Cartilage allograft plug
US20040267362 *30 juin 200330 déc. 2004Julia HwangScaffold for connective tissue repair
US20050027307 *15 juil. 20023 févr. 2005Schwartz Herbert EugeneUnitary surgical device and method
US20050038520 *11 août 200317 févr. 2005Francois BinetteMethod and apparatus for resurfacing an articular surface
US20050090139 *7 mars 200328 avr. 2005Rowland WhiteContact
US20050119756 *5 janv. 20052 juin 2005Tecres S.P.A.Disposable articulated spacing device for surgical treatment of joints of the human body
US20050125073 *8 déc. 20039 juin 2005Orban Janine M.Implant device for cartilage regeneration in load bearing articulation regions
US20050125077 *5 déc. 20039 juin 2005Harmon Alexander M.Viable tissue repair implants and methods of use
US20050222687 *2 avr. 20046 oct. 2005Gordana Vunjak-NovakovicCartilage implant assembly and method for implantation
US20050249771 *20 avr. 200510 nov. 2005Prasanna MalaviyaHybrid biologic-synthetic bioabsorbable scaffolds
US20050249772 *20 avr. 200510 nov. 2005Prasanna MalaviyaHybrid biologic-synthetic bioabsorbable scaffolds
US20050251268 *14 juin 200510 nov. 2005Musculoskeletal Transplant FoundationCartilage allograft plug
US20060095053 *28 oct. 20054 mai 2006Zannis Anthony DMethod of delivering therapeutic implant
US20060095054 *28 oct. 20054 mai 2006Zannis Anthony DInstruments, kit and method for suture management
US20060128296 *29 oct. 200415 juin 2006Schwan Wade EIntestine processing device and associated method
US20060135638 *22 déc. 200422 juin 2006Pedrozo Hugo AMethod for organizing the assembly of collagen fibers and compositions formed therefrom
US20060178680 *7 févr. 200610 août 2006Regen Biologics, Inc.System and method for all-inside suture fixation for implant attachment and soft tissue repair
US20060189993 *20 avr. 200624 août 2006Arthrotek, Inc.Soft tissue conduit device
US20060190042 *3 févr. 200624 août 2006Arthrotek, Inc.Tissue repair assembly
US20060210643 *16 mars 200521 sept. 2006Truncale Katherine A GCartilage repair mixture containing allograft chondrocytes
US20060211953 *28 oct. 200521 sept. 2006Zannis Anthony DCoordinate instrument set
US20060263335 *29 mars 200423 nov. 2006Regentec Ltd.Porous matrix
US20060271201 *25 mai 200530 nov. 2006Biomet Manufacturing Corp.Porous ceramic structure containing biologics
US20060273050 *25 mai 20067 déc. 2006Higgins Joel CApparatus and method for separating and concentrating fluids containing multiple components
US20070034579 *19 oct. 200615 févr. 2007Randel DorianMethods and apparatus for isolating platelets from blood
US20070129811 *10 oct. 20067 juin 2007Plouhar Pamela LReinforced small intestinal submucosa
US20070162055 *15 févr. 200712 juil. 2007Bowman Steven MGraft fixation device combination
US20070276191 *26 mai 200629 nov. 2007Sean SeloverIlluminated surgical access system including a surgical access device and integrated light emitter
US20080071385 *29 nov. 200720 mars 2008Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US20080082128 *29 sept. 20063 avr. 2008Arthrotek, Inc.Method and apparatus for forming a self-locking adjustable suture loop
US20080125863 *28 nov. 200629 mai 2008Mckay William FImplant designs and methods of improving cartilage repair
US20080133008 *31 janv. 20085 juin 2008Muscuoskeletal Transplant FoundationCartilage repair mixture containing allograft chondrocytes
US20080140094 *11 déc. 200612 juin 2008Schwartz Herbert EUnitary surgical device and method
US20080217264 *19 mai 200811 sept. 2008Biomet Manufacturing Corp.Apparatus And Method For Separating And Concentrating Fluids Containing Multiple Components
US20080217265 *19 mai 200811 sept. 2008Biomet Manufacturing Corp.Apparatus And Method for Separating And Concentrating Fluids Containing Multiple Components
US20080255676 *24 janv. 200716 oct. 2008Musculoskeletal Transplant FoundationTwo piece cancellous construct for cartilage repair
US20080269762 *25 avr. 200730 oct. 2008Biomet Manufacturing Corp.Method and device for repair of cartilage defects
US20080274157 *26 mars 20086 nov. 2008Gordana Vunjak-NovakovicCartilage implant plug with fibrin glue and method for implantation
US20080283474 *11 avr. 200820 nov. 2008Biomet Biologics, LlcBuoy suspension fractionation system
US20090101599 *29 déc. 200823 avr. 2009Hanuman, L.L.C.Methods And Apparatus For Isolating Platelets From Blood
US20090149893 *4 déc. 200811 juin 2009Semler Eric JCancellous Bone Implant for Cartilage Repair
US20090221075 *27 févr. 20093 sept. 2009Biomet Manufacturing Corp.System And Process For Separating A Material
US20090291112 *9 févr. 200926 nov. 2009Truncale Katherine GAllograft osteochondral plug combined with cartilage particle mixture
US20090319045 *5 mars 200924 déc. 2009Truncale Katherine GCancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US20100015202 *24 juil. 200921 janv. 2010Semler Eric JCancellous construct with support ring for repair of osteochondral defects
US20100222882 *26 févr. 20102 sept. 2010Badylak Stephen FJoint bioscaffolds
US20100256595 *3 avr. 20097 oct. 2010Biomet Biologics, LlcAll-In-One Means Of Separating Blood Components
US20110009963 *21 sept. 201013 janv. 2011Depuy Mitek, Inc.Biocompatible scaffold for ligament or tendon repair
US20110014705 *16 juil. 200920 janv. 2011Biomet Biologics, LlcMethod and apparatus for separating biological materials
US20110056893 *15 nov. 201010 mars 2011Biomet Biologics, LLC.Apparatus and Method for Separating and Concentrating Fluids Containing Multiple Components
US20110091517 *22 nov. 201021 avr. 2011Depuy Mitek, Inc.Biocompatible scaffolds with tissue fragments
US20110097381 *29 déc. 201028 avr. 2011Depuy Mitek, Inc.Conformable tissue repair implant capable of injection delivery
US20110168193 *25 mars 201114 juil. 2011Biomet Biologics, LlcApparatus and Method for Separating and Concentrating Fluids Containing Multiple Components
US20110177134 *1 févr. 201121 juil. 2011Depuy Mitek, Inc.Viable Tissue Repair Implants and Methods of Use
US20110185560 *18 févr. 20114 août 2011Qioptiq Photonics Gmbh & Co. KgMethod for producing an objective
US20120114755 *22 juin 201010 mai 2012Mayo Foundation For Medical Education And ResearchMethods and materials for tissue repair
US20130060334 *23 févr. 20117 mars 2013Orteq B.V.Meniscus repair assembly and method
US20150224147 *30 janv. 201313 août 2015Nu Tech Medical, Inc.Placental Membrane Preparation and Methods of Making and Using Same
USRE4220826 juin 20088 mars 2011Musculoskeletal Transplant FoundationGlue for cartilage repair
USRE4325813 déc. 201020 mars 2012Musculoskeletal Transplant FoundationGlue for cartilage repair
EP1652473A128 oct. 20053 mai 2006DePuy Products, Inc.Implant system with sizing templates
EP1652484A128 oct. 20053 mai 2006DePuy Products, Inc.Instruments, kit and method for suture managment
WO2011005185A1 *12 juil. 201013 janv. 2011Milux Holding S.A.Implantable medical device for lubrication of a synovial joint and method for implanting the device
Classifications
Classification aux États-Unis623/23.57, 623/23.63, 424/423
Classification internationaleA61P19/00, C12N5/08, A61F2/28, A61F2/46, A61L27/00, A61L27/36, A61F2/30, A61F2/00, A61L27/18, A61L27/56, A61F2/44, A61F2/38, A61B17/04, A61L31/00, A61B17/064, A61B17/00, A61F2/08, A61B17/06, A61F2/02
Classification coopérativeA61F2002/30878, A61L31/005, A61F2002/30764, A61F2002/30281, A61F2002/30217, A61L27/3852, A61F2/3094, A61F2002/30429, A61F2240/001, A61F2230/0019, A61F2002/30294, A61F2002/2817, A61F2240/004, A61L27/3654, A61F2230/0013, A61F2002/30891, A61B2017/0475, A61F2/30749, A61B2017/0647, A61F2230/0082, A61L2430/06, A61F2002/30233, A61F2002/30153, A61F2002/30062, A61F2002/30892, A61F2002/30225, A61L27/3633, A61F2/3872, A61F2002/30914, A61F2002/30766, A61F2002/2839, A61F2002/3021, A61B2017/0646, A61F2230/0063, A61F2002/30224, A61B17/0642, A61F2002/30199, A61F2/30756, A61F2002/30611, A61F2/442, A61F2002/30957, A61F2002/30293, A61F2002/30032, A61F2/30965, A61B2017/00004, A61B2017/06057, A61L27/3604, A61F2250/003, A61F2002/30841, A61F2002/30971, A61F2210/0004, A61L27/18, A61F2002/30785, A61F2002/30131, A61B17/064, A61F2250/0063, A61F2002/30848, A61F2230/0091, A61B17/0401, A61F2002/30678, A61F2/08, A61F2230/0067, A61F2002/30751, A61F2/0811, A61F2220/0025, A61F2/0063, A61L27/3683, A61B2017/0641, A61F2/28, A61F2002/30975, A61L27/56, A61B17/06166, A61F2002/30677, A61F2002/30261, A61F2002/3096, A61F2230/0086, A61F2230/0069, A61F2250/0067, A61F2310/00365
Classification européenneA61L27/36B14, A61L27/36F2D, A61L27/38D2D, A61L27/18, A61L27/36B, A61F2/08F, A61L27/36H, A61F2/00H, A61L27/56, A61F2/30C, A61F2/28, A61B17/064, A61F2/30B10, A61F2/08, A61B17/064B, A61L31/00F, A61F2/38M
Événements juridiques
DateCodeÉvénementDescription
19 janv. 2010ASAssignment
Owner name: DEPUY PRODUCTS, INC., INDIANA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PLOUHAR, PAMELA L.;SCHWARTZ, HERBERT E.;MALAVIYA, PRASANNA;REEL/FRAME:023809/0475;SIGNING DATES FROM 20050802 TO 20090806